Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University462 Ruijin Hospital282 Shanghai Zhongshan Hospital169 RenJi Hospital133 Children's Hospital of Fudan University84
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Shanghai

3879 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
530
Shanghai
2026-06-01
Recruiting
Huashan Hospital
Early Phase 1
10
Shanghai
2026-06-01
Recruiting
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
104
Shanghai
2026-06-01
Not yet open
King's College London
Observational
20
Shanghai
2026-06-01
Not yet open
Shanghai Children's Medical Center
Observational
1,400
Shanghai
2026-06-01
Recruiting
Neoadjuvant Chemoradiotherapy Combined With QL1706 for MSS-Type Low-Rectal Cancer
NCT07866313MSS-type Low Rectal Cancer，Neoadjuvant Chemoradiotherapy, QL1706
DrugIparomlimab and Tuvonralimab
Changhai Hospital
Phase 2/3
60
Shanghai
2026-06-01
Recruiting
Long Jiang
Phase 4
150
Shanghai
2026-06-01
Not yet open
Shanghai Zhongshan Hospital
Phase 3
304
Shanghai
2026-06-01
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
24
Shanghai
2026-06-01
Recruiting
Ruijin Hospital
Phase 1/2
30
Shanghai
2026-06-01
Not yet open
Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC
NCT07494435Hepato Cellular Carcinoma (HCC), Renal Cell Cancer
DrugsWGI-0301·Nivolumab
Zhejiang Haichang Biotech Co., Ltd.
Phase 2
230
Shanghai
2026-06-01
Not yet open
Shanghai Zhongshan Hospital
Not applicable
2,488
Shanghai
2026-06-01
Not yet open
Multicenter Study of Transcranial Magnetic Stimulation on Vision Restoration
NCT07425717Retinal Degeneration, Vision Impairment and Blindness
Shanghai High Myopia Study Group
Not applicable
136
Hong Kong, Shanghai
2026-06-01
Not yet open
Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research
NCT07611695Pulmonary Tuberculosis, Tuberculosis (TB), Tuberculosis Active
Huashan Hospital
Observational
31,600
Changsha, Shanghai
2026-06-01
Not yet open
Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion
NCT07670338Malignant Pleural Effusions (Mpe)
Shanghai Chest Hospital
Not applicable
308
Wuhan, Xinxiang, Weifang, Shanghai
2026-06-01
Recruiting
Jie Liang
Not applicable
600
Beijing, Shenyang, Xining, Xi'an, Shanghai, Changzhi, Linfen, Yuncheng
2026-06-01
By invitation
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer
NCT07583160Metastatic Castration-Resistant Prostate Cancer Patients, Castration-Resistant Prostate Cancer (CRPC), Prostate Neoplasms
Changhai Hospital
Phase 1
18
Shanghai
2026-06-01
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
76
Beijing, Guangzhou, Qingdao, Shanghai
2026-06-01
Recruiting
Observational Cohort Study on Ocular Chronic Graft-Versus-Host Disease
NCT07794800Chronic Graft Versus Host Disease in Eye
Ruijin Hospital
Observational
340
Shanghai
2026-06-01
Recruiting
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
130
Shanghai
2026-06-01
Not yet open
Surgical Robot or Static Guide for Dental Implant Placement
NCT07577245Partial Edentulism Class II
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
112
Xi’an, Shanghai
2026-06-01
Recruiting
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma
NCT07652489Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
70
Harbin, Changsha, Shenyang, Shanghai, Xi’an, Wenzhou
2026-06-01
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
R1 Therapeutics
Phase 2
168
Beijing, Zhengzhou, Nanjing, Shanghai, Chengdu
2026-06-01
Not yet open
Shanghai Zhongshan Hospital
Phase 2
58
Shanghai
2026-06-01
Recruiting
Shanghai East Hospital
Observational
20
Shanghai
2026-06-01
Not yet open
CLASSYS Inc.
Not applicable
252
Chengdu, Chongqing, Hebei, Shanghai
2026-06
Not yet open
Vertebrobasilar Dolichoectasia Treatment With Amiloride
NCT07634068Vertebrobasilar Dolichoectasia
Huashan Hospital
Phase 2
6
Shanghai
2026-06
Not yet open
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
50
Shanghai
2026-06
Recruiting
Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
NCT07616037PCOS (Polycystic Ovary Syndrome)
Shanghai Zhongshan Hospital
Phase 2
30
Shanghai
2026-06
Not yet open
Fudan University
Phase 2
165
Shanghai
2026-06
Not yet open
Probiotics Supplementation for Neurodevelopment in Preterm Infants
NCT07617181Premature Birth, Neurodevelopmental Disorders, Dysbiosis
Fudan University
Not applicable
116
Shanghai
2026-06
Not yet open
Sd-RAB for the Diagnosis of PPNs
NCT06719687Peripheral Pulmonary Nodules
Shanghai Chest Hospital
Not applicable
30
Shanghai
2026-06
Not yet open
Vertebrobasilar Dolichoectasia Treatment With Sirolimus
NCT07634120Vertebrobasilar Dolichoectasia
DrugSirolimus
Huashan Hospital
Phase 2
12
Shanghai
2026-06
Not yet open
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
NCT07583771Pancreatic Adenocarcinoma, Non Small Cell Lung Cancer, Advanced Solid Tumors, Lymphoma
Chipscreen Biosciences, Ltd.
Phase 1
186
Shanghai
2026-06
Not yet open
AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study)
NCT07640906Thoracic Diseases, Chest CT Scan, Artificial Intelligence (AI) in Diagnosis
Shanghai Zhongshan Hospital
Observational
75
Shanghai
2026-06
Not yet open
RenJi Hospital
Phase 2
50
Shanghai
2026-05-31
Not yet open
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Recruiting
Community-based Screening for Alzheimer's Disease
NCT07570719Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Cognitive Impairment
Kuang XiaoJun
Observational
3,000
Shanghai
2026-05-27
Recruiting
Ruijin Hospital
Phase 1
30
Shanghai
2026-05-26
Recruiting
Shanghai Public Health Clinical Center
Not applicable
60
Shanghai
2026-05-26
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
16
Shanghai
2026-05-25
Recruiting
Effects of Probiotics on the Gut-brain Axis in Children
NCT07459699Attention Deficit Hyperactivity Disorder (ADHD)
Probi AB
Not applicable
80
Shanghai
2026-05-25
Recruiting
Vivacta Biotechnology (Shanghai) Co., Ltd.
Early Phase 1
22
Shanghai
2026-05-25
Not yet open
AI vs. Physician for Anti-VEGF Decision-Making: An RCT
NCT07328776DME, Retinal Vein Occlusion (RVO), Neovascular (Wet) Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2026-05-25
Recruiting
Yanbing Yu
Not applicable
142
Beijing, Nanning, Shijiazhuang, Nanjing, Nantong, Nanchang, Shanghai, Tianjin
2026-05-23
Recruiting
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS
NCT07607418AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome)
DrugIvosidenib
Ruijin Hospital
Phase 2
20
Shanghai
2026-05-22
Recruiting
Shanghai Henlius Biotech
Phase 1
41
Chongqing, Jinan, Shanghai, Wuhan
2026-05-22
Recruiting
C Ray Therapeutics
Phase 1/2
90
Taiyuan, Shanghai
2026-05-22
Recruiting
Fudan University
Observational
1,000
Shanghai
2026-05-22
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing, Ankang, Datong, Ganzhou, Hangzhou, Huaian, Nanning, Shanghai
2026-05-22
Recruiting
Shanghai Zhongshan Hospital
Phase 2
30
Shanghai
2026-05-22
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou
2026-05-21
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
5,000
Shanghai
2026-05-20
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
32
Shanghai
2026-05-20
Recruiting
Ruijin Hospital
Early Phase 1
24
Shanghai
2026-05-18
Active, closed
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 1
24
Shanghai
2026-05-18
Recruiting
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
96
Shanghai
2026-05-18
Not yet open
Fudan University
Phase 3
420
Shanghai
2026-05-18
Not yet open
HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC
NCT07591805Upper Urinary Tract Urothelial Carcinoma
DrugDisitamab Vedotin
RenJi Hospital
Phase 2
49
Shanghai
2026-05-16
Recruiting
Fudan University
Observational
300
Shanghai
2026-05-15
Not yet open
Safety and Efficacy of High-Channel Implanted BCI for Motor Function Improvement in Tetraplegia Patients
NCT07457645Tetraplegic Motor Dysfunction Following Brainstem or Spinal Cord Injury
Shanghai Zhongshan Hospital
Not applicable
10
Shanghai
2026-05-15
Not yet open
Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors
NCT07558200Solid Tumors, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma
DrugTEV-56278
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
138
Shanghai
2026-05-15
Recruiting
Ipsen
Phase 3
350
Beijing, Guangzhou, Zhengzhou, Nanchang, Changchun, Jinan, Shanghai, Tianjin
2026-05-14
Not yet open
Ruijin Hospital
Phase 2
60
Shanghai
2026-05-14
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
24
Shanghai
2026-05-14
Recruiting
Fudan University
Observational
5,390
Shanghai
2026-05-14
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
DrugsPF-08634404·Nivolumab
Pfizer
Phase 2/3
840
Guangzhou, Wuhan, Shanghai, Chengdu
2026-05-14
Recruiting
Ruijin Hospital
Phase 1
18
Shanghai
2026-05-13
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626Pancreatic Tumor, Benign, Pancreatic Cancer, Adult, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
320
Changsha, Shanghai, Xi’an
2026-05-11
Recruiting
CGM for Insulin-Treated T2DM During Post-Discharge Transition
NCT07414277Type 2 Diabetes Mellitus (T2DM)
Shanghai 6th People's Hospital
Not applicable
160
Shanghai
2026-05-11
Active, closed
SPH-BIOCAD (HK) Limited
Phase 1
48
Shanghai
2026-05-11
Recruiting
Fudan University
Phase 2
40
Shanghai
2026-05-10
Not yet open
RDN for Heart Failure
NCT07558902Heart Failure
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
20
Shanghai
2026-05-10
Not yet open
Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy
NCT07601386CIPN - Chemotherapy-Induced Peripheral Neuropathy
Shanghai Jeyou Pharmaceutical Co., Ltd.
Phase 1
18
Shanghai
2026-05-10
Not yet open
Ruijin Hospital
Phase 2
178
Shanghai
2026-05-06
Recruiting
Fudan University
Observational
5,000
Shanghai
2026-05-06
Recruiting
Hoffmann-La Roche
Phase 3
8
Guangzhou, Shanghai
2026-05-06
Recruiting
Fudan University
Phase 3
280
Shanghai
2026-05-06
Recruiting
Jing-yuan Fang, MD, Ph. D
Not applicable
20
Shanghai
2026-05-06
Recruiting
Impact of Hyperemic State on Angio-IMR Performance
NCT07613996Coronary Artery Disease, Microvascular Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
192
Shanghai, Guangzhou
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Beijing, Fuzhou, Guangzhou, Zhengzhou, Shanghai
2026-05-03
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
256
Shanghai
2026-05-01
Recruiting
Fudan University
Phase 3
759
Shanghai
2026-05-01
Recruiting
Yung NA
Phase 2
68
Shanghai
2026-05-01
Recruiting
Eye & ENT Hospital of Fudan University
Observational
200
Shanghai
2026-05-01
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
66
Shanghai
2026-05-01
Recruiting
Ruijin Hospital
Phase 2
205
Shanghai
2026-05-01
Not yet open
Fudan University
Phase 2
300
Shanghai
2026-05-01
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
DrugsGilteritinib·Sorafenib
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
290
Shanghai
2026-05-01
Not yet open
Kousai Bio Co., Ltd.
Phase 1
55
Wuhan, Shanghai
2026-05-01
Not yet open
SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer
NCT07551479Locally Advanced Rectal Cancer (LARC), MSS (Microsatellite Stable)
DrugsCapecitabine·Oxaliplatin
Fudan University
Phase 3
612
Shanghai
2026-05-01
Not yet open
Shanghai Chest Hospital
Not applicable
76
Shanghai
2026-05-01
Active, closed
Wenjin Yin
Observational
2,946
Shanghai
2026-05-01
By invitation
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients
NCT07370441End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD), Nutritional Status, Renal Replacement Therapy
DrugAmino acid (15) peritoneal dialysis
Shanghai 10th People's Hospital
Phase 4
50
Shanghai
2026-05-01
Active, closed
Wenjin Yin
Observational
188
Shanghai
2026-05-01
Recruiting
BCI With 40Hz Stimulation in Alzheimer's Disease
NCT07618481Alzheimer Dementia (AD)
Ruijin Hospital
Not applicable
90
Shanghai
2026-05-01
Recruiting
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
NCT07570745Graft-Versus-Host Disease(GVHD), Bone Marrow Transplantation
DrugsPTCy·Ivarmacitinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
82
Shanghai
2026-05-01
Recruiting
RenJi Hospital
Phase 2
55
Shanghai
2026-05-01
Not yet open
Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer
NCT07550205Ovarian Neoplasms Malignant, Sleep Initiation and Maintenance Disorders, Medicine, Chinese Traditional, Chinese Herbal Medicine
Shanghai Municipal Hospital of Traditional Chinese Medicine
Phase 2/3
360
Shanghai
2026-05-01
Not yet open
Shanghai Mental Health Center
Not applicable
120
Shanghai
2026-05-01
Not yet open
Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL
NCT07613788Relapsed/Refractory Large B-cell Lymphoma (LBCL)
DrugsRimegepant·Glofitamab·Obinutuzumab·Fludarabine
Ruijin Hospital
Phase 2
100
Shanghai
2026-05
Not yet open
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
NCT07595120Pulmonary Nodules, Early-Stage Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
400
Shanghai
2026-05
Not yet open
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
NCT07579247HIV, AIDS, Immune Checkpoint Inhibitors, Refractory Opportunistic Infection
DrugSintilimab
Shanghai Public Health Clinical Center
Phase 1/2
50
Shanghai
2026-05
Not yet open
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
356
Shanghai
2026-05
Not yet open
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
NCT07014878Colorectal Cancer, Lung Cancer, Pancreatic Cancer
Beijing DCTY Biotech Co.,Ltd.
Phase 1
18
Shanghai
2026-05
Recruiting
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
NCT07614061Biliary Tract Neoplasms, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Perihilar
DrugCyclophosphamide and Fludarabine
Shanghai Zhongshan Hospital
Phase 1
18
Shanghai
2026-05
Not yet open
Shanghai Mental Health Center
Phase 1
9
Shanghai
2026-05
By invitation
Anemia on Sublingual Microcirculation in GDFT
NCT07583927Anemia in Patients Undergoing Gastric Cancer Surgery Under Goal-directed Fluid Therapy, Macro-microcirculation Uncoupling
Fudan University
Observational
54
Shanghai
2026-05
Recruiting
Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease
NCT07588854Chronic Liver Disease (CLD), Liver Fibrosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
65
Shanghai
2026-05
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Shanghai
2026-04-30
Active, closed
DiproBio (Shanghai) Co., Ltd.
Observational
106,667
Shanghai
2026-04-30
Not yet open
A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens
NCT07469488NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4
122
Shanghai
2026-04-30
Not yet open
Inhaled Nitric Oxide for Prevention of Postoperative AKI in High-Risk Cardiac Surgery Patients
NCT07544147Cardiac Surgery Associated - Acute Kidney Injury, Cardiac Surgery With Cardiopulmonary Bypass
DrugNitric Oxide
Shanghai Zhongshan Hospital
Not applicable
330
Shanghai
2026-04-30
Not yet open
xieqing
Observational
10,000
Shanghai
2026-04-30
Not yet open
Shanghai Zhongshan Hospital
Phase 1
24
Shanghai
2026-04-30
Recruiting
Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma
NCT07502768Extranodal NK/T-cell Lymphoma, NK/T-cell Lymphoma, Relapsed or Refractory NK/T-Cell Lymphoma
DrugsZeprumetostat·Tislelizumab
Rong Tao
Phase 1/2
107
Shanghai
2026-04-30
Recruiting
Tongji University
Phase 2
150
Shanghai
2026-04-30
Recruiting
Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC
NCT07403136Esophageal Squamous Cell Carcinoma
Fudan University
Phase 2
104
Shanghai
2026-04-30
Recruiting
ChinaNorm
Not applicable
76
Shanghai
2026-04-28
Recruiting
Shanghai StairMed Technology Co., Ltd.
Not applicable
34
Shanghai
2026-04-28
Recruiting
Biogen
Phase 3
30
Zhengzhou, Guangzhou, Shanghai
2026-04-28
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
40
Shanghai
2026-04-28
Recruiting
Dragonboat Biopharmaceutical Company Limited
Phase 2
96
Shanghai
2026-04-27
Not yet open
Shanghai Mental Health Center
Not applicable
158
Shanghai
2026-04-25
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
80
Shanghai
2026-04-25
Recruiting
Ruijin Hospital
Phase 2
60
Shanghai
2026-04-24
Recruiting
SKB103 for Injection in Advanced Solid Tumors
NCT07459998Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
277
Harbin, Shanghai
2026-04-23
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
336
Shanghai
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Not yet open
Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery
NCT07521787Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness
Shanghai Zhongshan Hospital
Observational
540
Shanghai
2026-04-23
Recruiting
International Peace Maternity and Child Health Hospital
Phase 2
29
Shanghai
2026-04-23
Recruiting
Ruijin Hospital
Not applicable
1,950
Shanghai
2026-04-22
Recruiting
Ruijin Hospital
Phase 2
88
Shanghai
2026-04-21
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1
100
Shanghai
2026-04-21
Recruiting
JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study
NCT07518160Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
DrugJS111
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
35
Shanghai
2026-04-21
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
44
Shanghai
2026-04-20
Recruiting
LinGang Laboratory
Phase 1
100
Shanghai
2026-04-20
Recruiting
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Not yet open
Trans-round Window Membrane Intracochlear Steroid
NCT07540728Sudden Hearing Loss
Eye & ENT Hospital of Fudan University
Phase 2
108
Shanghai
2026-04-20
Not yet open
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL
NCT07548255Intermediate-to-High-Risk Mantle Cell Lymphoma, the Efficacy and Safety
DrugObinutuzumab
Ruijin Hospital
Phase 1
28
Shanghai
2026-04-20
Recruiting
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07601737Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy
DrugsAlbumin-Bound Paclitaxel /nab-Paclitaxel·Nimotuzumab·Tislelizumab·Docetaxel
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
182
Shanghai
2026-04-20
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
160
Shanghai
2026-04-18
Recruiting
Ruijin Hospital
Phase 2
74
Shanghai
2026-04-17
Recruiting
Shanghai Henlius Biotech
Phase 1
138
Beijing, Shanghai
2026-04-17
Recruiting
Fudan University
Phase 2
40
Shanghai
2026-04-17
Recruiting
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Not yet open
Ruijin Hospital
Observational
64
Shanghai
2026-04-15
Not yet open
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
255
Shanghai
2026-04-15
Not yet open
Shanghai 10th People's Hospital
Observational
88
Shanghai
2026-04-15
Recruiting
Hoffmann-La Roche
Phase 3
100
Hangzhou, Shanghai
2026-04-15
Recruiting
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07493135Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd
Early Phase 1
30
Beijing, Chongqing, Shanghai, Zhengzhou
2026-04-14
Recruiting
Eli Lilly and Company
Phase 2
65
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
DrugLY4005130
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Recruiting
Acupuncture Therapy for Sudden Sensorineural Hearing Loss
NCT07575334Sudden Sensorineural Hearing Loss (SSNHL)
Eye & ENT Hospital of Fudan University
Not applicable
256
Shanghai
2026-04-13
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Recruiting
miRNA Panel for PCa Diagnosis
NCT07755592Prostate Cancer (Diagnosis)
RenJi Hospital
Observational
500
Shanghai
2026-04-13
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
10
Shanghai
2026-04-13
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
192
Shanghai
2026-04-13
Recruiting
BeOne Medicines
Phase 1
84
Beijing, Chongqing, Fuzhou, Guangzhou, Yichang, Shanghai
2026-04-13
Recruiting
Fudan University
Not applicable
20
Shanghai
2026-04-13
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
63
Shanghai
2026-04-10
Not yet open
VAH vs VA in Newly Diagnosed Elderly AML
NCT07469046Acute Myeloid Leukemia (AML), Elderly Patients (60-75 Years)
DrugsHomoharringtonine·Azacitidine·Venetoclax
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3
308
Shanghai
2026-04-10
Recruiting
Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness
NCT07571226Major Depressive Disorder (MDD), Anxiety Disorder, Alcohol Use Disorder (AUD)
Huashan Hospital
Observational
680
Beijing, Shanghai
2026-04-10
Recruiting
Shanghai University of Sport
Not applicable
18
Shanghai
2026-04-10
Not yet open
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2026-04-10
Recruiting
magAssist, Inc.
Not applicable
204
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Shenyang, Suzhou, Xi'an
2026-04-09
Recruiting
Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery
NCT07229495Scoliosis; Adolescence, Pain After Surgery, Analgesia, Patient-controlled
DrugsTegileridine·Morphine
Peking Union Medical College Hospital
Phase 4
171
Zhengzhou, Nanchang, Beijing, Shanghai
2026-04-08
Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
NCT07403721Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen
Phase 1
464
Guangzhou, Shanghai
2026-04-08
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
280
Chongqing, Shanghai
2026-04-08
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
370
Huangshan City, Wuhu, Beijing, Zhanjiang, Changsha, Changchun, Linyi, Shanghai
2026-04-07
Recruiting
Shanghai Chest Hospital
Not applicable
204
Shanghai
2026-04-07
Not yet open
ChinaNorm
Not applicable
90
Shanghai
2026-04-07
Recruiting
Shanghai East Hospital
Not applicable
1,235
Shanghai
2026-04-05
Recruiting
Urinary Cell-Free DNA Liquid Biopsy for Urothelial Cancer Diagnosis and Origin Identification
NCT07888374Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, Bladder Cancer
Ruijin Hospital
Observational
477
Shanghai
2026-04-05
Not yet open
CorrectSequence Therapeutics Co., Ltd
Phase 2
20
Nanning, Shanghai
2026-04-05
Recruiting
Shanghai Synvida Biotechnology Co.,Ltd.
Phase 1
60
Shanghai
2026-04-04
Recruiting
Shanghai University of Sport
Not applicable
98
Shanghai
2026-04-04
Recruiting
Shanghai Mental Health Center
Not applicable
100
Shanghai
2026-04-03
Recruiting
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
248
Beijing, Shanghai
2026-04-03
Recruiting
Fudan University
Phase 3
2,288
Shanghai
2026-04-03
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
70
Shanghai
2026-04-03
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
DrugsCS060380·Semaglutide
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Recruiting
A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
NCT07288580Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Shanghai Euhearing Therapeutics Co., Ltd
Phase 1/2
30
Shanghai
2026-04-02
Recruiting
Changhai Hospital
Not applicable
150
Fuzhou, Quanzhou, Guangzhou, Qingyuan, Zhanjiang, Shanghai
2026-04-02
Active, closed
Safety and Efficacy of Intrathecal NTF001 Injection in ALS
NCT07618585ALS - Amyotrophic Lateral Sclerosis, ALS (Amyotrophic Lateral Sclerosis)
Ruijin Hospital
Phase 1
12
Shanghai
2026-04-01
Recruiting
Ruijin Hospital
Observational
170
Shanghai
2026-04-01
Not yet open
TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery
NCT07494591Ipsilateral Shoulder Pain, Video-Assisted Thoracoscopic Surgery
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
216
Shanghai
2026-04-01
Not yet open
Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma
NCT07469735Glioma, Diffuse Glioma, Recurrent Gliomas
Huashan Hospital
Not applicable
10
Shanghai
2026-04-01
Recruiting
Fudan University
Phase 2
53
Shanghai
2026-04-01
By invitation
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2026-04-01
Not yet open
Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology
NCT07466810Tongue Squamous Cell Carcinoma, Mixed Reality, Virtual Surgical Planning, Free Flap
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
30
Shanghai
2026-04-01
By invitation
Fudan University
Observational
44
Shanghai
2026-04-01
Recruiting
Optimizing Early Nutrition Management of Extremely and/or Very Preterm Infants
NCT07538999Nutrition Intervention, Quality Improvement, Preterm Infant
Children's Hospital of Fudan University
Not applicable
200
Shanghai
2026-04-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
45
Shanghai
2026-04-01
Active, closed
Shanghai Fourth People's Hospital Tongji University
Not applicable
152
Shanghai
2026-04-01
Active, closed
Keda Yu
Not applicable
66
Shanghai
2026-04-01
Recruiting
Beijing Boren Hospital
Early Phase 1
2
Beijing, Shanghai
2026-04-01
Recruiting
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
NCT07565532Small Cell Lung Cancer ( SCLC ), Radiotherapy, Immunotherapy, Personalized Cancer Treatment
Shanghai Chest Hospital
Observational
500
Shanghai
2026-04-01
Recruiting
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
NCT07564557Non-small Cell Lung Cancer, Early-stage Lung Cancer, Deep-seated Lung Nodules, Solid-dominant Lung Cancer
Shanghai Chest Hospital
Not applicable
89
Shanghai
2026-04-01
Not yet open
Jin LI
Not applicable
30
Shanghai
2026-04-01
Active, closed
Radiomics Features Predicting Outcomes of PAD
NCT07602634Peripheral Artery Disease (PAD)
Zhijun Bao
Observational
200
Shanghai
2026-04-01
Not yet open
Children's Hospital of Fudan University
Phase 4
6
Shanghai
2026-04
Recruiting
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
NCT07528105T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital
Early Phase 1
9
Shanghai
2026-04
Not yet open
Fudan University
Phase 2
37
Shanghai
2026-04
Not yet open
Shanghai Yueyang Integrated Medicine Hospital
Phase 2
60
Shanghai
2026-04
Recruiting
Shanghai Mental Health Center
Observational
400
Shanghai
2026-04
Not yet open
Ruijin Hospital
Observational
750
Shanghai
2026-04
Not yet open
Chipscreen Biosciences, Ltd.
Phase 3
558
Shanghai
2026-03-31
Recruiting
Ruijin Hospital
Phase 2
30
Shanghai
2026-03-31
Recruiting
Shanghai Tong Ren Hospital
Not applicable
35
Zunyi, Shanghai
2026-03-31
By invitation
Ruijin Hospital
Observational
150
Shanghai
2026-03-31
Not yet open
Ruijin Hospital
Phase 3
156
Shanghai
2026-03-31
Active, closed
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 3
367
Shanghai
2026-03-31
Active, closed
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
NCT07749703Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
346
Hefei, Shenyang, Jinan, Shanghai, Hangzhou
2026-03-31
Recruiting
TaiRx, Inc.
Phase 2
40
Fuzhou, Shanghai
2026-03-31
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Shanghai
2026-03-31
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 2
372
Shanghai
2026-03-31
Recruiting
Cosiporfin Sodium for Injection Photodynamic Therapy
NCT07398339Biliary Tract Cancers (BTC)
DrugsGemcitabine·Cisplatin
Shanghai Guangsheng Biopharmaceutical Co., Ltd
Phase 2
30
Shanghai
2026-03-31
Not yet open
Shanghai Chest Hospital
Phase 2
19
Shanghai
2026-03-30
By invitation
Knee Pain Ejiao Paste for Knee Osteoarthritis
NCT07504562Knee Osteoarthritis
ShuGuang Hospital
Phase 2
60
Shanghai
2026-03-30
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
NCT07535762Peripheral T-Cell Lymphoma (PTCL NOS), Nodal T-follicular Helper Cell Lymphoma, Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
DrugsAclarubicin·Vincristine·Prednisone·Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 2
36
Shanghai, Wuxi
2026-03-30
Recruiting
Fudan University
Not applicable
120
Shanghai
2026-03-30
Active, closed
ChunBao Li
Not applicable
270
Beijing, Shenzhen, Luoyang, Nanjing, Xi'an, Tai’an, Shanghai, Chengdu
2026-03-30
Recruiting
BioNTech SE
Phase 1/2
533
Chongqing, Guangzhou, Hangzhou, Shanghai, Tianjin
2026-03-30
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
NCT07535710Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, Sezary Syndrome, Cutaneous T Cell Lymphoma (CTCL)
DrugsAclarubicin·Vincristine·Prednisone·Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 1/2
37
Shanghai, Wuxi
2026-03-30
Not yet open
Changhai Hospital
Observational
169
Shanghai
2026-03-30
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 2
48
Shanghai
2026-03-30
Active, closed
Hoffmann-La Roche
Phase 1
30
Nanjing, Shanghai
2026-03-30
Recruiting
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
NCT06889610Triple Negative Breast Cancer Metastatic, Melanoma Metastatic, Colorectal Cancer Metastatic
Fudan University
Phase 2
95
Shanghai
2026-03-30
Not yet open
Shanghai Best-Link Bioscience, LLC
Phase 1/2
48
Shanghai
2026-03-27
Recruiting
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
NCT07300514Maintenance Treatment of Peripheral T-cell Lymphoma
DrugGolidocitinib
Fudan University
Phase 3
136
Shanghai
2026-03-27
Recruiting
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 2/3
680
Hefei, Shanghai
2026-03-27
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
DrugZigakibart
Novartis Pharmaceuticals
Phase 2
32
Beijing, Shanghai
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Beijing, Changchun, Guangdong, Guangzhou, Jinan, Nanchang, Shanghai, Zhengzhou
2026-03-26
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
151
Beijing, Shanghai
2026-03-25
Recruiting
Fudan University
Not applicable
66
Shanghai
2026-03-25
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Fuzhou, Guangzhou, Wuhan, Changsha, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-24
Recruiting
Study of ABO2102 in KRAS-Mutated Solid Tumors
NCT07455617Advanced / Metastatic Solid Tumor
DrugsABO2102·Sintilimab
Suzhou Abogen Biosciences Co., Ltd.
Phase 1
101
Shanghai
2026-03-24
Recruiting
MTS109 in Patients With Refractory Autoimmune Diseases
NCT07526350Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Systemic Sclerosis (SSc), ANCA-Associated Vasculitis (AAV)
Shanghai Changzheng Hospital
Early Phase 1
15
Shanghai
2026-03-24
Recruiting
Boehringer Ingelheim
Phase 2
132
Beijing, Chengdu, Guangzhou, Nanchang, Nanjing, Nanning, Shanghai, Sichuan
2026-03-23
Recruiting
DXP-106 in Solid Tumor Patients.
NCT07532018Solid Tumor, Cancer
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.
Phase 1
54
Harbin, Shanghai, Taiyuan, Hangzhou
2026-03-23
Recruiting
Ruijin Hospital
Phase 2
50
Shanghai
2026-03-23
Recruiting
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
NCT07309055Adolescents With Moderate-to-severe Atopic Dermatitis
DrugSHR-1819
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
201
Shenyang, Shanghai
2026-03-21
Recruiting
ChinaNorm
Observational
20
Shanghai
2026-03-21
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Hutchmed
Phase 3
240
Shanghai, Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing
2026-03-20
Active, closed
International Peace Maternity and Child Health Hospital
Phase 1/2
60
Shanghai
2026-03-20
Recruiting
Ji Dongmei
Phase 2
90
Shanghai
2026-03-19
Recruiting
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Atamparib in Patients With Advanced Solid Tumors
NCT07374419NSCLC Adenocarcinoma, Solid Tumor
Nerviano Medical Sciences (Shanghai) Ltd.
Phase 1/2
178
Shanghai
2026-03-18
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
440
Shanghai, Hangzhou
2026-03-18
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
8
Shanghai
2026-03-18
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
376
Shanghai
2026-03-17
Recruiting
PregnAncy-Related Aortic DISsEction in China
NCT07672210Pregnancy Complication, Aortic Dissection, Marfan Syndrome, Loeys-Dietz Syndrome
DeltaHealth Hospital · Shanghai
Observational
500
Shanghai, Beijing, Guangzhou, Wuhan
2026-03-17
Active, closed
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 3
600
Shanghai
2026-03-17
Active, closed
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
150
Shanghai
2026-03-17
Recruiting
A Study of MHB009C in Patients With Advanced Solid Tumors
NCT07326488Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
200
Shanghai
2026-03-17
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
56
Shanghai
2026-03-16
Recruiting
United Innomed(Shanghai) Limited
Not applicable
330
Fuzhou, Lanzhou, Guangzhou, Guiyang, Zhengzhou, Changsha, Nanchang, Shanghai
2026-03-16
Not yet open
Fudan University
Phase 2
30
Shanghai
2026-03-15
Recruiting
Fudan University
Not applicable
1,036
Shanghai
2026-03-15
Active, closed
Forward Pharmaceuticals Co., Ltd.
Phase 1
18
Shanghai
2026-03-15
Not yet open
Shanghai 7th People's Hospital
Phase 2
60
Shanghai
2026-03-15
Not yet open
Zhigang Li
Phase 2
33
Shanghai
2026-03-15
Not yet open
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
NCT07486726Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia (AML)
DrugsAclarubicin·Azacitidine·Venetoclax
Shanghai Jiao Tong University School of Medicine
Phase 1/2
112
Shanghai
2026-03-15
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
30
Shanghai
2026-03-13
Recruiting
Sanofi
Phase 2/3
526
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Shanghai
2026-03-13
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Hefei, Shanghai, Guangzhou, Zhengzhou, Hangzhou, Nanjing, Xuzhou, Nanchang
2026-03-13
Recruiting
A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
NCT07469982Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion
Shouyao Holdings (Beijing) Co. LTD
Phase 1
122
Shanghai
2026-03-12
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Shanghai, Chengdu, Beijing, Langfang
2026-03-12
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
24
Shanghai
2026-03-11
Recruiting
Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions
NCT07462247Upper Gastrointestinal Cancer, Upper Gastrointestinal Precancerous Lesions, Upper Gastrointestinal Precancerous Conditions
Changhai Hospital
Observational
500
Shanghai
2026-03-11
Recruiting
Fudan University
Phase 2
45
Shanghai
2026-03-11
Recruiting
Shanghai 6th People's Hospital
Phase 4
200
Shanghai
2026-03-10
Not yet open
Shanghai Zhongshan Hospital
Not applicable
24
Nanchang, Shanghai
2026-03-10
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Guangzhou, Wuhan, Beijing, Shanghai
2026-03-09
Recruiting
Eli Lilly and Company
Phase 4
150
Beijing, Changsha, Guangdong, Guangzhou, Lanzhou, Nanchang, Shanghai, Taizhou
2026-03-09
Recruiting
Beijing Sungen Biomedical Technology Co., Ltd
Phase 2
210
Shanghai
2026-03-09
Recruiting
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
84
Guangzhou, Shanghai
2026-03-09
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
92
Shanghai
2026-03-09
Not yet open
Chaigui Longmu Ejiao Paste for Ischemic Heart Disease
NCT07478328Ischemic Heart Disease
Longhua Hospital
Phase 2
60
Shanghai
2026-03-08
Recruiting
Shanghai JMT-Bio Inc.
Phase 3
1,800
Shanghai
2026-03-06
Recruiting
AstraZeneca
Observational
2,100
Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Nantong, Shanghai
2026-03-06
Recruiting
Takeda
Observational
12
Guangzhou, Shanghai, Hangzhou
2026-03-05
Recruiting
SKB105 for Injection in Advanced Solid Tumors
NCT07380386Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
256
Beijing, Shanghai
2026-03-05
By invitation
Shanghai University of Sport
Not applicable
80
Shanghai
2026-03-04
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 3
5,500
Nanjing, Shanghai
2026-03-04
Recruiting
Hutchmed
Phase 1/2
186
Changchun, Changsha, Jinan, Nanning, Shanghai, Wuhan, Xiamen, Zhengzhou
2026-03-04
Recruiting
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
NCT07445048Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer, Postoperative Adjuvant Treatment
DrugNimotuzumab
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 3
370
Shanghai
2026-03-04
Recruiting
Prediction Model for Postoperative Cognitive Dysfunction in Elderly Cardiac Patients: A Special Disease Cohort Study
NCT07483047Postoperative Cognitive Dysfunction (POCD), Cardiac Diseases Requiring Surgery
Shanghai Geriatric Medical Center
Observational
634
Shanghai
2026-03-03
Recruiting
Janssen Research & Development, LLC
Phase 1/2
60
Guangzhou, Harbin, Shanghai
2026-03-03
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
96
Shanghai
2026-03-03
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1/2
401
Shanghai
2026-03-02
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
180
Beijing, Shanghai
2026-03-02
Recruiting
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
140
Shanghai
2026-03-02
Recruiting
SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
NCT07451795Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)
Fudan University
Phase 2
66
Fujian, Shanghai, Xiamen
2026-03-02
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-03-02
By invitation
Children's Hospital of Fudan University
Observational
1,500
Shanghai
2026-03-01
By invitation
Children's Hospital of Fudan University
Observational
500
Shanghai
2026-03-01
Recruiting
AI-Powered Precision Decision-Making for Pancreatic Diseases
NCT07439757Pancreatic Cancer, Diagnose Disease, IPMN, Pancreatic, Pancreatic Cystic Lesions
Changhai Hospital
Observational
2,000
Shanghai
2026-03-01
Recruiting
RenJi Hospital
Phase 2
46
Shanghai
2026-03-01
Recruiting
Shanghai Zhongshan Hospital
Phase 2
35
Shanghai
2026-03-01
Recruiting
AI-Driven Autonomous Registration in Robotic Bronchoscopy
NCT07368829Lung Nodules, Bronchoscopy, Localization Efficiency
Ruijin Hospital
Not applicable
20
Shanghai
2026-03-01
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
2,000
Shanghai
2026-03-01
Recruiting
Unidade Local de Saúde São João, Oporto
Not applicable
20
Shanghai
2026-03-01
Not yet open
Fudan University
Phase 2
300
Shanghai
2026-03-01
Active, closed
Midline Catheter Study
NCT07610681Child Health
Children's Hospital of Fudan University
Observational
428
Shanghai
2026-03-01
Recruiting
Ruijin Hospital
Phase 1/2
180
Shanghai
2026-03-01
Not yet open
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
NCT07446465Colorectal Cancer (Locally Advanced or Metastatic), Colorectal Cancer Microsatellite Stable (MSS)
DrugsMFOLFOX6·Fruquintinib·Serplulimab
Ye Xu
Phase 4
42
Shanghai
2026-03-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2026-03-01
Recruiting
Application of Child Life Services in Pediatric Skin Prick Test
NCT07319273Hypersensitivity, Pediatrics
Children's Hospital of Fudan University
Not applicable
140
Shanghai
2026-03-01
Not yet open
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 2/3
120
Nanjing, Shanghai
2026-03-01
Not yet open
Clinical Implementation of the Group Standard for Enteral Feeding Care in Critically Ill Children
NCT07441746Clinical Implementation, Standardized Tube Feeding Care, Enteral Nutrition
Children's Hospital of Fudan University
Not applicable
500
Shanghai
2026-03
Not yet open
YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases
NCT07439029Systemic Lupus Erythematosus (SLE), Diffuse Systemic Sclerosis, Idiopathic Inflammatory Myopathies (IIMs), ANCA Associated Vasculitis (AAV)
DrugYTS109 cell
Children's Hospital of Fudan University
Phase 1
12
Shanghai
2026-03
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
54
Shanghai
2026-03
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2/3
116
Shanghai
2026-03
Recruiting
Ruijin Hospital
Phase 2
47
Shanghai
2026-03
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
32
Shanghai
2026-03
Not yet open
Akeso
Phase 2
160
Guangzhou, Shanghai
2026-02-28
Not yet open
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 3
524
Shanghai
2026-02-28
Not yet open
Fecal Molecular Susceptibility-guided Hp Rescue Therapy
NCT07405697Helicobacter Pylori Infection
Shanghai Zhongshan Hospital
Phase 4
290
Shanghai
2026-02-28
Recruiting
Ruijin Hospital
Phase 3
218
Shanghai
2026-02-28
Not yet open
Fecal Molecular Susceptibility-guided Hp First-line Therapy
NCT07405684HELICOBACTER PYLORI INFECTIONS
Shanghai Zhongshan Hospital
Phase 4
544
Shanghai
2026-02-28
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
70
Nanjing, Shanghai
2026-02-27
Recruiting
Beijing Anzhen Hospital
Not applicable
252
Beijing, Dalian, Jilin City, Nanchang, Shanghai
2026-02-26
Not yet open
Fudan University
Phase 3
248
Shanghai
2026-02-26
Recruiting
Beijing Anzhen Hospital
Not applicable
564
Beijing, Changchun, Dalian, Nanchang, Shanghai
2026-02-25
Recruiting
Shanghai Changzheng Hospital
Phase 2
37
Shanghai
2026-02-24
Not yet open
Suzhou Genhouse Bio Co., Ltd.
Phase 1/2
152
Shanghai
2026-02-24
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
528
Shanghai, Taiyuan, Hangzhou, Huzhou, Jinhua, Ningbo, Shanhu
2026-02-23
Not yet open
Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)
NCT07393438Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis, MDR-TB, RR-TB
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
120
Hefei, Shanghai
2026-02-21
Recruiting
TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
NCT07514065Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd
Phase 1
78
Shanghai
2026-02-20
Recruiting
Beijing Daxiang Biotech Co., Ltd
Observational
164
Shanghai
2026-02-20
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07246096Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis, Primary Sjögren Syndrome
Changhai Hospital
Early Phase 1
60
Shanghai
2026-02-20
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1
21
Beijing, Luoyang, Wuhan, Shanghai
2026-02-19
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Guangzhou, Shanghai
2026-02-17
Not yet open
Shanghai Mental Health Center
Not applicable
60
Shanghai
2026-02-15
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3
68
Shanghai
2026-02-15
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Recruiting
CAR-NK Cells (CL-NK-003) in Pancreatic Cancer
NCT07425483Pancreatic Cancer
Changhai Hospital
Phase 1
9
Shanghai
2026-02-12
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
280
Shanghai
2026-02-11
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
340
Shanghai
2026-02-09
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Beijing, Chaoyang District, Guangzhou, Shanghai
2026-02-08
Recruiting
Shanghai Changzheng Hospital
Observational
52
Shanghai
2026-02-06
Recruiting
A Study of PLB-002 in Advanced Solid Tumors
NCT07304128Advanced Solid Tumor
Primelink BioTherapeitics(ShenZhen) Limited
Phase 1
100
Shanghai
2026-02-06
Recruiting
Jiangxi Kvvit Pharmaceutical Co., Ltd.
Phase 1
92
Shanghai
2026-02-05
Recruiting
An Antibody-armored Dendritic Cell in Patients With Solid Tumors
NCT07479667Solid Cancers, Adjuvant Therapy
Shanghai Cell Therapy Group Co.,Ltd
Phase 1
8
Shanghai
2026-02-05
Recruiting
Fudan University
Phase 2
116
Shanghai
2026-02-05
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Observational
14,300
Shijiazhuang, Zhengzhou, Changchun, Shenyang, Shanghai, Kunming
2026-02-05
Recruiting
Wenxian Li
Not applicable
336
Wuwei, Shenzhen, Baoding, Pizhou, Shanghai, Neijiang
2026-02-04
Recruiting
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
Novartis Pharmaceuticals
Observational
170
Shanghai
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
Shanghai Mental Health Center
Not applicable
64
Shanghai
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 1/2
240
Beijing, Shanghai
2026-02-03
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 2
50
Shanghai
2026-02-02
Recruiting
Fudan University
Phase 2
58
Shanghai
2026-02-02
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
370
Shanghai
2026-02-02
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
111
Harbin, Hefei, Shanghai, Xi'an, Zhengzhou
2026-02-01
Not yet open
Shanghai Mental Health Center
Observational
100
Shanghai
2026-02-01
Recruiting
Efficacy of Montelukast on STEMl Patients
NCT07320625Myocardial Infarction (MI)
DrugMontelukast
Shanghai Zhongshan Hospital
Phase 3
512
Dalian, Shanghai, Fuzhou, Guangdong, Ha’erbin, Hefei, Hunan, Shenyang
2026-02-01
Recruiting
A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children
NCT07375602Congenital Heart Disease (CHD), Ventricular Septal Defects (VSD), Cardiac Catheterization, Postoperative Complications
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
5,249
Shanghai
2026-02-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4
249
Shanghai
2026-02-01
Recruiting
Shanghai Children's Medical Center
Observational
1,000
Shanghai
2026-02-01
Not yet open
Fudan University
Phase 2
114
Shanghai
2026-02-01
Not yet open
Shanghai Mental Health Center
Observational
100
Shanghai
2026-02-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
500
Shanghai
2026-02-01
Not yet open
Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery
NCT07348328Cardiovascular Surgical Procedures, Major Adverse Cardiovascular Events (MACE)
Nanjing Medical University
Not applicable
1,000
Shanghai, Nanjing
2026-02-01
Recruiting
Early Sepsis Recognition Tool
NCT07397689Infection, Sepsis
KK Women's and Children's Hospital
Observational
40,000
Shanghai
2026-02-01
Recruiting
Biochemical Response and Clinical Outcomes in Patients With PBC
NCT07449793Primary Biliary Cholangitis (PBC), Primary Biliary Cholangitis
RenJi Hospital
Observational
3,000
Shanghai
2026-02-01
Not yet open
Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
NCT07405658Kawasaki Disease, Chest X-ray for Clinical Evaluation, Mucocutaneous Lymph Node Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
20,000
Shanghai
2026-02-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2/3
40
Shanghai
2026-02-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
180
Zhenzhou, Yantai, Shanghai
2026-02-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2026-02-01
Recruiting
Shanghai Zhongshan Hospital
Not applicable
656
Shanghai
2026-02-01
By invitation
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
252
Shanghai
2026-02-01
By invitation
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
72
Shanghai
2026-02-01
Recruiting
Cognitive Effects of Hesperidin in Overweight/Obese Older Adults
NCT07750223Cognitive Dysfunction, Overweight and Obesity
Min Hou
Not applicable
105
Shanghai
2026-02-01
Recruiting
Support System Design for Adolescent Scoliosis Orthosis Wear
NCT07574229Adolescent Idiopathic Scoliosis (AIS), Adherence
Shanghai Jiao Tong University School of Medicine
Not applicable
18
Shanghai
2026-02-01
Not yet open
Shanghai Zhongshan Hospital
Not applicable
202
Shanghai
2026-02-01
Recruiting
Jun Zhang
Not applicable
78
Shanghai
2026-02-01
Not yet open
Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis
NCT07328074Thymic Epithelial Tumor, Thymoma, Thymic Carcinoma, Pleural Metastasis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
70
Shanghai
2026-02
Not yet open
Fudan University
Phase 2
48
Shanghai
2026-02
Not yet open
Shanghai Changzheng Hospital
Early Phase 1
10
Shanghai
2026-02
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Early Phase 1
20
Shanghai
2026-02
Not yet open
Shanghai Changzheng Hospital
Early Phase 1
40
Shanghai
2026-02
Not yet open
Fudan University
Observational
200
Shanghai
2026-01-31
Recruiting
Shanghai Zhongshan Hospital
Not applicable
17
Shanghai
2026-01-31
Not yet open
Compound Granules of Hedyotis Diffusa for Chronic Atrophic Gastritis
NCT07391800Chronic Atrophic Gastritis With Hyperplasia (Diagnosis)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
20
Shanghai
2026-01-31
Recruiting
Shanghai Changzheng Hospital
Observational
100
Shanghai
2026-01-31
Not yet open
Eastern Hepatobiliary Surgery Hospital
Phase 2
56
Shanghai
2026-01-30
Not yet open
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3
1,208
Shanghai
2026-01-30
Not yet open
Shanghai Zhongshan Hospital
Not applicable
1,200
Shanghai
2026-01-30
Not yet open
Ruijin Hospital
Phase 2
19
Shanghai
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
DrugsSigvotatug vedotin·PF-08634404
Pfizer
Phase 1/2
162
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Recruiting
Genmab
Phase 2
240
Shanghai, Beijing, Changchun, Nanjing, Tianjin, Zhangjiakou, Zhengzhou
2026-01-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Beijing, Fuzhou, Guangzhou, Jiangmen, Harbin, Nanchang, Shanghai, Chengdu
2026-01-29
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
5
Shanghai
2026-01-29
Recruiting
Fudan University
Phase 2
276
Shanghai
2026-01-29
Recruiting
Hope Medicine (Nanjing) Co., Ltd
Phase 3
540
Beijing, Nanning, Suzhu, Shanghai, Tianjin
2026-01-29
Not yet open
Fudan University
Phase 4
40
Xuzhou, Shanghai
2026-01-28
Recruiting
Shanghai Huihe Medical Technology Co., Ltd
Not applicable
132
Shanghai
2026-01-28
Recruiting
Fudan University
Phase 4
110
Shanghai
2026-01-28
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai
2026-01-27
Active, closed
Takeda
Phase 2
91
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2026-01-26
Recruiting
Shanghai Jiao Tong University School of Medicine
Early Phase 1
15
Shanghai
2026-01-26
Recruiting
Fudan University
Phase 2/3
260
Shanghai
2026-01-25
Recruiting
Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients
NCT07521111Critical Illness, Enteral Nutrition Intolerance, Enteral Nutrition Feeding, Prediction Models
Ruijin Hospital
Observational
500
Shanghai
2026-01-25
Recruiting
Shanghai Mental Health Center
Observational
121
Suzhou, Xuzhou, Shanghai, Hangzhou, Ningbo
2026-01-24
Recruiting
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase 3
230
Shanghai
2026-01-23
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
864
Shanghai
2026-01-23
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
86
Beijing, Fuzhou, Meizhou, Shanghai, Chengdu
2026-01-22
Recruiting
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
NCT07422857Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia
Drug[18F]-APN-1607
JYAMS PET Research & Development Limited
Phase 3
316
Wuhan, Shanghai
2026-01-22
Recruiting
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
NCT07413341Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), Systemic Sclerosis (SSc), Inflammatory Myopathy
Therorna
Phase 1
12
Shanghai
2026-01-22
Recruiting
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
NCT07269106Ophthalmic Surgery, Postoperative Pain Management, Opioid Analgesia
DrugsAnrikefon·Nalbuphine
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase 4
204
Guangzhou, Kunming, Shanghai
2026-01-22
Recruiting
Sanofi
Phase 3
751
Guangzhou, Huizhou, Shanghai, Wuxi
2026-01-22
Recruiting
G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
NCT07362810Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB), Hematopoetic Stem Cell Transplantation, Hemato-oncologic Patients
DrugG-Csf
Fudan University
Phase 2
224
Fuzhou, Zhengzhou, Nanchang, Shanghai, Hangzhou
2026-01-22
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
100
Shanghai
2026-01-20
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
160
Shanghai
2026-01-20
Recruiting
Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices
NCT07358663Esophagogastric Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,384
Shanghai
2026-01-20
Not yet open
Shanghai Yueyang Integrated Medicine Hospital
Observational
450
Shanghai
2026-01-20
Recruiting
Shanghai Henlius Biotech
Phase 2
60
Shanghai
2026-01-20
Recruiting
Fudan University
Phase 2
350
Shanghai
2026-01-19
Recruiting
First in Human Study of SIM0610 in Solid Tumors
NCT07348211Advanced Solid Tumours, Non-Small Cell Lung Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
260
Chongqing, Harbin, Shenyang, Jinan, Shanghai
2026-01-19
Recruiting
Shanghai 10th People's Hospital
Observational
198
Shanghai
2026-01-16
Not yet open
Shanghai 10th People's Hospital
Not applicable
60
Shanghai
2026-01-16
Recruiting
A Study of MHB048C in Patients With Advanced Solid Tumors
NCT07192120mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
200
Shanghai
2026-01-16
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
300
Shanghai
2026-01-16
Recruiting
Sanofi
Phase 3
751
Guangzhou, Huizhou, Wuxi, Chengdu, Beijing, Hefei, Kunming, Shanghai
2026-01-16
Recruiting
Efficacy and Safety of Rifaximin-α in Treating MASLD
NCT07381257Metabolic Dysfunction-Associated Steatotic Liver Disease
DrugRifaximin
Shanghai Changzheng Hospital
Early Phase 1
60
Shanghai
2026-01-15
Recruiting
BioNTech SE
Phase 2
75
Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan
2026-01-15
Not yet open
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 3
480
Shanghai
2026-01-15
Recruiting
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
NCT07279259Stroke, Acute Ischemic Stroke, Thrombolysis
Shanghai East Hospital
Phase 2
340
Shanghai
2026-01-15
Not yet open
Huaier Granule and Proteinuria
NCT07355361Proteinuria, Breast Cancer Patients
DrugHuaier
Fudan University
Phase 2
120
Shanghai
2026-01-15
Active, closed
Janssen Research & Development, LLC
Phase 2
157
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Hangzhou, Ningbo, Shanghai
2026-01-15
Not yet open
Ruijin Hospital
Phase 1
20
Shanghai
2026-01-15
Not yet open
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 3
500
Shanghai
2026-01-15
Recruiting
ChinaNorm
Observational
100
Shanghai
2026-01-15
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
18
Shanghai
2026-01-14
Active, closed
Ruijin Hospital
Observational
200
Shanghai
2026-01-13
By invitation
Xiangya Hospital of Central South University
Observational
1,500
Beijing, Guangzhou, Jinan, Shanghai
2026-01-13
Recruiting
InventisBio Co., Ltd
Phase 3
477
Shanghai
2026-01-12
Recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
74
Shanghai
2026-01-12
Recruiting
Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients
NCT07820254Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Shanghai Pulmonary Hospital, Shanghai, China
Observational
60
Shanghai
2026-01-10
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
54
Shanghai
2026-01-10
Not yet open
Fudan University
Phase 2
38
Shanghai
2026-01-09
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
258
Shanghai
2026-01-09
Active, closed
Shanghai East Hospital
Observational
10,000
Shanghai
2026-01-08
Recruiting
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
NCT07275788Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics
Phase 1
15
Shanghai
2026-01-08
Recruiting
Novo Nordisk A/S
Phase 3
460
Beijing, Zhengzhou, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2026-01-08
Not yet open
Shanghai East Hospital
Not applicable
150
Shanghai
2026-01-07
Recruiting
Fudan University
Phase 2
100
Shanghai
2026-01-07
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
198
Shanghai
2026-01-07
Recruiting
IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer
NCT07408635Unresectable Stage III Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
DrugLenvatinib
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
43
Shanghai
2026-01-07
Active, closed
MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer
NCT07692230HR Positive/HER-2 Negative Breast Cancer
Fudan University
Observational
2,000
Shanghai
2026-01-06
Not yet open
Phase I Study of FXS887 in the Treatment of Solid Tumors
NCT07345637Solid Tumor Refractory to Conventional Treatment
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
14
Shanghai
2026-01-05
Recruiting
Essilor International
Not applicable
40
Shanghai
2026-01-02
Recruiting
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 4
40
Shanghai
2026-01-02
Recruiting
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 4
40
Shanghai
2026-01-02
Not yet open
Stereotactic Aspiration of Brain Stem Hematoma
NCT07300501Brain Stem Hematoma
First Affiliated Hospital of Zhejiang University
Not applicable
300
Hangzhou, Changsha, Guangzhou, Jinan, Shanghai, Shenzhen, Taizhou, Wenzhou
2026-01-01
Recruiting
Fudan University
Phase 2
24
Shanghai
2026-01-01
Not yet open
Shanghai Zhongshan Hospital
Phase 2
69
Shanghai
2026-01-01
Not yet open
Ruijin Hospital
Not applicable
40
Shanghai
2026-01-01
By invitation
Shanghai Jiao Tong University School of Medicine
Observational
36
Shanghai
2026-01-01
Not yet open
Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors
NCT07282873Solid Tumor Malignancies, Malignant Mesothelioma (MM)
TYK Medicines, Inc
Phase 1/2
219
Shanghai
2026-01-01
Recruiting
Shanghai 10th People's Hospital
Not applicable
50
Shanghai
2026-01-01
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
30
Shanghai
2026-01-01
Not yet open
Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension
NCT06783296Hypertension, Renal Denervation Therapy
Shanghai 10th People's Hospital
Not applicable
124
Shanghai
2026-01-01
Recruiting
Acepodia Biotech, Inc.
Phase 1/2
34
Beijing, Chengdu, Hangzhou, Hefei, Shanghai, Taiyuan, Wuhan
2026-01-01
Recruiting
Very Early PCSK9 Inhibition for Acute Myocardial Infarction
NCT07208006Acute Myocardial Infarction (AMI)
Shanghai Zhongshan Hospital
Not applicable
1,518
Shanghai
2026-01-01
Recruiting
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
NCT07367724Obstructive Hypertrophic Cardiomyopathy (oHCM)
DrugTransmeti
China National Center for Cardiovascular Diseases
Phase 2
44
Beijing, Shanghai, Xinjiang
2026-01-01
Active, closed
Ruijin Hospital
Observational
200
Shanghai
2026-01-01
Not yet open
SMART-IC-Pilot Study
NCT07336433Hypertensive Disease
SyMap Medical (Suzhou), Ltd.
Not applicable
15
Shanghai
2026-01-01
Not yet open
Shanghai Zhongshan Hospital
Not applicable
178
Shanghai
2026-01-01
Not yet open
Shanghai Chest Hospital
Not applicable
280
Shanghai
2026-01-01
Recruiting
Shanghai Changzheng Hospital
Observational
1,200
Shanghai
2026-01-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
36
Shanghai
2026-01-01
Active, closed
First Affiliated Hospital of Fujian Medical University
Observational
288
Fuzhou, Shanghai
2026-01-01
Recruiting
Shanghai 10th People's Hospital
Observational
50
Shanghai
2026-01-01
Not yet open
New Pattern of Retinal Laser Treatment for PDR
NCT07315802Proliferative Diabetic Retinopathy, Photocoagulation Burn to Retina
Eye & ENT Hospital of Fudan University
Not applicable
300
Shanghai
2026-01-01
Not yet open
Fudan University
Phase 3
210
Shanghai
2026-01-01
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 3
356
Shanghai
2026-01-01
Recruiting
Fudan University
Phase 2
600
Shanghai
2026-01-01
Recruiting
Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
NCT07381738Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection, EBV Associated Lymphoma, Umbilical Cord Blood Transplant
Fudan University
Phase 2
80
Shanghai
2026-01-01
Recruiting
Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC
NCT07290153Breast Cancer Female NOS, General Anxiety Disorder, Depressive Disorder
Fudan University
Observational
120
Shanghai
2026-01-01
Active, closed
Shanghai Chest Hospital
Not applicable
86
Shanghai
2026-01-01
Recruiting
Retrograde Ascending Dissection: Intraluminal Aortic Therapy
NCT07405242Ascending Aortic Dissection
Ruijin Hospital
Not applicable
149
Shanghai
2026-01-01
Not yet open
Shanghai Zhongshan Hospital
Phase 1/2
42
Shanghai
2026-01-01
Recruiting
Jin Yang
Not applicable
400
Shanghai
2026-01-01
Recruiting
Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease
NCT07353853IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation
Changhai Hospital
Not applicable
1,000
Shanghai
2026-01-01
Not yet open
Guangzhou University of Traditional Chinese Medicine
Observational
3,000
Beijing, Guangzhou, Weihui, Shanghai, Chengdu
2026-01
Not yet open
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD
Phase 1
36
Bengbu, Beijing, Luoyang, Wuhan, Nanjing, Shanghai
2026-01
Not yet open
JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer
NCT07336771Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
DrugsD-0502·JSKN016
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1/2
60
Shanghai
2026-01
Not yet open
Shanghai Children's Medical Center
Observational
400
Shanghai
2026-01
Not yet open
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
NCT07294300Relapsed/Refractory Hematological Malignancies
Qilu Pharmaceutical Co., Ltd.
Phase 1
124
Shanghai
2026-01
Not yet open
Suzhou UgeneX Therapeutics Co., Ltd.
Early Phase 1
6
Shanghai
2026-01
Not yet open
AI for Renal Tumors Using Non-Contrast CT
NCT07304492Renal Neoplasms, Renal Cyst
Fudan University
Observational
10,000
Shanghai
2026-01
Rows per page Showing 501–1000 of 3879
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,879 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,418 of the 3,879 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 756 have not yet opened recruitment, 598 are active but closed to new participants, and 107 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.